Grace Wong

CSO, ActoKine Therapeutics

Dr. Grace Wong has worked for Genentech, Millennium, AstraZeneca and Serono on new drug discovery in a variety of therapeutic areas. Dr. Wong earned a PhD at The Walter and Eliza Hall Institute of Medical Research in Australia. Dr. Wong did a postdoc with Dr. David Goeddel at Genentech and advanced basic research discoveries to product development. In 1996, Dr. Wong became the Head of Apoptosis Research at Millennium Pharmaceuticals, worked at AstraZeneca as Section Head of Molecular Genetics and at Serono as Head of Functional Genomics. She has been awarded 13 scholarships from Australian and American organizations and received 5 Recognition Awards from Genentech.

Dr. Wong has been invited to give presentations at 153 international conferences including the Nobel Symposium (Sweden, 1994). She has published 93 papers and filed 28 patents. Some of her publications (3 Nature, 1 Science, 3 Cell, 5 PNAS, and 7 J. Immunol) have received 300-1000 citations.

Dr. Wong has founded Actokine Therapeutics (www.actokine.com) for new drug advancements for cancer, obesity, CNS and emerging viral diseases. She also founded Student Vision (www.studentvision.org) and the Nobel Pauling Symposia (www.pauling.us) to help scientists of all ages in biotechnology.


 

 

Massachusetts Institute of Technology ◎2006 | Fabricant by AISpace